“…Taken together, observations that serotonin precursors and agonists decrease the phaseshifting response to light (Glass et al, 1995;Rea et al, 1994), and that clorgyline elevates 5-HT within the SCN (Ozaki et al, 1993), raise the possibility that clorgyline's enhancement of 5-HT function may mediate clorgyline's attenuating effect on the pacemaker's phase-shifting response to light. With regard to lithium, there is also substantial evidence that it enhances serotonergic neurotransmission (de Montigny, 1981;de Montigny et al, 1988;Muller-Oerlinghausen 1985;Price et al, 1990) and alters retinal and pupillary func-tion (Reme et al, 1987(Reme et al, , 1988(Reme et al, , 1990Seggie, 1988;Seggie et al, 1989aSeggie et al, , 1989b. Therefore, it is possible that lithium's capacity to modify the effect of light input on the circadian pacemaker may be responsible for its reported capacity to facilitate entrainment to LD cycles that have periods greater than 24 h (McEachron et al, 1981;Reinhard, 1985;Schweizer et al, 1986).…”